Pan-Lin Asset Management

Total investments

50

Average round size

20M

Portfolio companies

37

Rounds per year

3.57

Lead investments

17

Follow on index

0.26

Exits

2

Stages of investment
Early Stage Venture
Areas of investment
BiotechnologySoftwareHealth CareManufacturingMedicalProduct DesignPharmaceuticalSemiconductorElectronicsIndustrial

Summary

The leading representative office of defined Corporate Investor is situated in the Shanghai. The venture was found in Asia in China.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Pan-Lin Asset Management, startups are often financed by Zhizhuo Capital, ZhenFund, OrbiMed. The meaningful sponsors for the fund in investment in the same round are Matrix Partners China, ZhenFund, South China Venture Capital. In the next rounds fund is usually obtained by Zhizhuo Capital, ZhenFund, Sigma Square Capital.

We can highlight the next thriving fund investment areas, such as Health Care, Enterprise. For fund there is a match between the location of its establishment and the land of its numerous investments - China. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 3 or 4 of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight YCloset, Apollomics, XGIMI. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.

The important activity for fund was in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. Speaking about the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations.

Show more

Investments analytics

Analytics

Total investments
50
Lead investments
17
Exits
2
Rounds per year
3.57
Follow on index
0.26
Investments by industry
  • Health Care (16)
  • Biotechnology (15)
  • Medical (11)
  • Manufacturing (11)
  • Electronics (6)
  • Show 47 more
Investments by region
  • China (44)
  • United States (3)
  • Canada (2)
Peak activity year
2021

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
7
Avg. valuation at time of investment
10M
Group Appearance index
0.80
Avg. company exit year
8
Avg. multiplicator
6.64

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
02 Jun 2010 Real Estate, Marketing Automation, Marketplace, Advertising, Ad Network, Lead Generation, Home Renovation Venture - Series Unknown 15M United States, " United States"}
Thorough Images 25 Nov 2019 Seed
Tingke Biotechnology 03 Mar 2023 Biotechnology, Manufacturing, Biopharma Early Stage Venture Hangzhou, Zhejiang, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.